Claude Nicaise

SRPT

Claude Nicaise serves as Director at Sarepta Therapeutics, Inc. (SRPT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$392.1K

Net Position

Net Seller

$392.1K

Companies Traded

SRPT

Active Period

Mar 2025 – Jan 2026

2 total trades

Most Recent

Sell SRPT

Jan 29, 2026 · $143.9K

Claude Nicaise's Insider Trading at Sarepta Therapeutics, Inc. (SRPT)

Buys

0 · $0.00

Sells

2 · $392.1K

Total Shares Bought

Total Shares Sold

9,271

SRPT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 29, 2026	Sell	6,780	$21.23	$143.9K	0
Mar 12, 2025	Sell	2,491	$99.64	$248.2K	0

Related Insiders

Stephen Mayo

director

SRPTSell · Mar 13, 2026

BEHRENS M KATHLEEN

Director

SRPTSell · Jan 27, 2026

Ian Michael Estepan

Chief Operating Officer

SRPTSell · Dec 16, 2025

Ryan Ho-Yan Wong

Chief Financial Officer

SRPTSell · Dec 1, 2025

Cristin Rothfuss

EVP, General Counsel

SRPTSell · Nov 28, 2025

Louise Rodino-Klapac

President, R&D and Tech Ops

SRPTSell · Nov 17, 2025

Explore More Insider Trading Data

SRPT Insider Trading Activity

View all insider trades at Sarepta Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity